Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intensive Hospital-based Adverse Drug Reaction Monitoring Study On Patients Treated By Qingkailing Injection In The Next Two Years

NCT01764204 is registered in ClinicalTrials.gov with China Academy of Chinese Medical Sciences as lead sponsor.

NCT NCT01764204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01764204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intensive Hospital-based Adverse Drug Reaction Monitoring Study On Patients Treated By Qingkailing Injection In The Next Two Years
Lead sponsor
China Academy of Chinese Medical Sciences
Phase
Observational
Overall status
Completed
Start date
January 31, 2013
Completion date
January 31, 2018
Enrollment
30,840 (actual)
Sites
48

Conditions

As the registry lists them; a condition with its own page is linked.

adverse drug events, adverse drug reactions